Cancer Chemotherapy and Pharmacology : Impact Factor & More
Aims and Scope of Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are E.Chatelut (Paul Sabatier University) and E.A. Sausville (University of Maryland). It has been included in Index medicus (MEDLINE) since its first issue. According to the ISI 2016 Journal Citation Reports, the journal has an impact factor of 2.737, and its ranking was 98/254 (Pharmacology & Pharmacy) and 122/217 (Oncology). Less
Key Metrics
Ensure manuscript complies with standard submission guidelines.
Improve clarity, grammar, and academic writing style.
Topics Covered on Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1978 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer Chemotherapy and Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
FAQs on Cancer Chemotherapy and Pharmacology
How long has Cancer Chemotherapy and Pharmacology been actively publishing? 
What is the publishing frequency of Cancer Chemotherapy and Pharmacology?
What is the eISSN & pISSN for Cancer Chemotherapy and Pharmacology?
What is Citescore for Cancer Chemotherapy and Pharmacology?
What is SNIP score for Cancer Chemotherapy and Pharmacology?
What is the SJR for Cancer Chemotherapy and Pharmacology?
Who is the publisher of Cancer Chemotherapy and Pharmacology?
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
Recommendations